Skip to main content
TipRanks
Go Ultimate75% OFF

MicroPort Scientific (MCRPF) AI Stock Analysis

7 Followers
MCRPF

MicroPort Scientific

(Other OTC:MCRPF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Diversified medical-device portfolio and international reachExposure across cardiovascular, orthopedic and other device categories can diversify procedure-driven revenue and reduce dependence on one product franchise. International sales and distribution also broaden commercialization opportunities beyond China, supporting a more resilient business model over the next several quarters.
Negative Factors
Revenue contraction signals an incomplete turnaroundRevenue contraction indicates that the return to accounting profitability has not yet been accompanied by renewed top-line momentum. Persistent weakness in sales can limit operating leverage, reduce the resources available for innovation, and make the broader turnaround less durable over the next several months.

MicroPort Scientific (MCRPF) vs. SPDR S&P 500 ETF (SPY)

-60%-40%-20%0%20%MCRPF-59.07%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.10B
Dividend Yield
―
Average Volume (3M)
20.00K
Price to Earnings (P/E)
31.2
Beta (1Y)
0.33
Revenue Growth
-3.51%
EPS Growth
―
Country
US
Employees
6,547
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

MicroPort Scientific Business Overview & Revenue Model

Company Description

MicroPort Scientific Corp. is an investment holding company, which engages in the research and development, manufacture, and distribution of medical devices. It operates through the following segments: Cardiovascular Devices Business, Orthopedics Dev...

MicroPort Scientific Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

MCRPF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:6609HK:660979OutperformHKD 2.06B17.547.90%―59.30%131.03%
HK:1302HK:130272OutperformHKD 6.57B103.381.71%―0.75%-20.22%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:6669HK:666951NeutralHKD 1.57B-24.52-3.50%―9.36%-153.54%
HK:9996HK:999645NeutralHKD 2.72B-15.40-7.65%―21.23%36.89%
HK:2393HK:239342NeutralHKD 97.84M-1.18-22.16%―-28.07%47.54%

* Healthcare Sector Average

Performance Comparison

-60%-40%-20%0%20%MCRPFHK:9996HK:6669HK:1302HK:2393HK:6609Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MCRPF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MCRPFMicroPort Scientific Corp0.57-0.83-59.22%
HK:9996Peijia Medical Ltd.3.83-2.31-37.62%
HK:6669Acotec Scientific Holdings Limited4.61-9.15-66.50%
HK:1302LifeTech Scientific Corporation1.54-0.31-16.49%
HK:2393Yestar Healthcare Holdings Co Ltd0.05-0.07-58.33%
HK:6609Shanghai Heartcare Medical Technology Corp. Ltd. Class H51.20-0.30-0.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.